Ai
OpenAI Researcher Eyes $2B AI Drug Discovery Startup
Miles Wang is leaving OpenAI to launch an AI drug discovery startup reportedly valued at $2 billion before its first clinical trial. The pharmaceutical industry's failure rate is broken and the money already knows